Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency

Eur J Neurol. 2001 Sep;8(5):477-81. doi: 10.1046/j.1468-1331.2001.00273.x.


Ataxia with vitamin E (Vit E) defciency (AVED) is an autosomal recessive disorder caused by mutations of the alpha tocopherol transfer protein gene. The Friedreich ataxia phenotype is the most frequent clinical presentation. In AVED patients, serum Vit E levels are very low in the absence of intestinal malabsorption. As Vit E is a major antioxidant agent, Vit E deficiency is supposed to be responsible for the pathological process. Twenty-four AVED patients were fully investigated (electromyography, nerve conduction velocity (NVC) studies, somatosensory evoked potentials, cerebral computed tomography scan, sural nerve biopsy, genetic studies) and supplemented with Vit E (800 mg daily) during a 1-year period. Clinical evaluation was mainly based on the Ataxia Rating Scale (ARS) for cerebellar ataxia assessment and serum Vit E levels were monitored. Serum Vit E levels normalized and ARS scores decreased moderately but significantly suggesting clinical improvement. Better results were noted with mean disease duration < or = 15 years. Reflexes remained abolished and posterior column disturbances unchanged. Vitamin E supplementation in AVED patients stabilizes the neurological signs and can lead to mild improvement of cerebellar ataxia, especially in early stages of the disease.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Cerebellar Ataxia / drug therapy*
  • Cerebellar Ataxia / genetics*
  • Electrophysiology
  • Evoked Potentials, Somatosensory / physiology
  • Female
  • Humans
  • Male
  • Neural Conduction / drug effects
  • Treatment Outcome
  • Vitamin E / therapeutic use*
  • Vitamin E Deficiency / drug therapy*
  • Vitamin E Deficiency / genetics*


  • Vitamin E